Collectively, the increased risk of IBD is primarily associated with higher levels of α-linolenic acid or lower levels of EPA, as the differences in desaturation steps driven by the FADS2 gene will lead to changes in both upstream α-linolenic acid and downstream EPA concentrations [7]. This evidence concerns the gene FADS2 and inflammatory bowel disease.